ORIGINAL RESEARCH PAPER
Regulating Effect of Phenolic Contents-abundant Plants on Acetylcholinesterase Enzyme Activity in Undifferentiated and Differentiated Human Neuroblastoma Cell Line (SHSY5Y)
 
More details
Hide details
1
Biology, University of Baghdad, Baghdad, Iraq
 
2
Biology, Mahasarakham University, Kham Riang, Thailand
 
3
Mathematics and Science, Rajamangala University of Technology Isan Surin Campus, Nok Mueang, Thailand
 
4
Pathology, Khon Kaen University, Khon Kaen, Thailand
 
5
Biochemistry, Thammasat University, Bangkok, Thailand
 
6
Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand
 
7
Biotechnology, Khon Kaen University, Thailand
 
 
Submission date: 2025-10-10
 
 
Final revision date: 2025-11-24
 
 
Acceptance date: 2026-01-25
 
 
Online publication date: 2026-03-28
 
 
Publication date: 2026-05-07
 
 
Corresponding author
Farah J. Hashim   

Biology, University of Baghdad, Baghdad, Iraq
 
 
NRFHH 2026;6(2):528-544
 
KEYWORDS
TOPICS
ABSTRACT
This study was aimed to detect the biological activity of Alpinia galanga rhizomes (ARE), Moringa oleifera leaves (MLE), A. galanga leaves (ALE), Panax ginseng leaves (PLE), P. ginseng rhizomes (PRE), and Vitis vinifera seeds (VSE) ethanolic extracts as acetylcholinesterase (AChE) inhibitors in both undifferentiated (undiff.) and differentiated (diff.) human neuroblastoma cell lines (SHSY5Y). AChE activity was estimated by Ellman’s colorimetric method. The bioactive compounds involved in the extract associated with impact on AChE activity were revealed by liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (LC–QTOF/MS). As a result, AChE inhibition was determined by ARE [PYL] (0.040 ± 0.026 mg/mL for undiff. cells and 0.048 ± 0.030 mg/mL for diff. cells), followed by MLE (0.150 ± 0.08 mg/mL for undiff. cells and 0.339 ± 0.020 mg/mL for diff. cells) when treated by MLE. The phytochemical analysis by LC–QTOF/MS identified abundant phenolic compounds, namely dephospho-CoA, nimodipine, and embelin, among the 40 compounds present in MLE, which have beneficial effects on AChE enzyme activity in undifferentiated and differentiated SHSY5Y cells. Furthermore, the compounds were estimated for the physicochemical and pharmacokinetic properties as well as molecular docking of ligand molecules and protein target prediction by freely accessible web tools, such as the PubChem database, SwissADME, and SwissDock.
REFERENCES (67)
1.
Ademosun A.O., Oboh G., Bello F., & Ayeni P.O., (2016). Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities. Journal of Evidence-based Complementary & Alternative Medicine. 21(4), NP11–NP17. 10.1177/2156587215610032
 
2.
Adewusi E.A., Moodley N., & Steenkamp V., (2010). Medicinal plants with cholinesterase inhibitory activity: A review. African Journal of Biotechnology. 9(49), 8257–8276. 10.4314/ajb.v9i49
 
3.
Al Rihani S.B., Lan R.S., Kaddoumi A, (2019). Granisetron alleviates Alzheimer’s disease pathology in TgSwDI mice through calmodulin-dependent protein kinase II/cAMP-response element binding protein pathway. Journal of Alzheimer’s Disease: JAD. 72(4), 1097–1117. 10.3233/JAD-190849
 
4.
Alcázar Magaña A., Kamimura N., Soumyanath A., Stevens J.F., & Maier C.S., (2021). Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity. The Plant Journal: For Cell and Molecular Biology. 107(5), 1299–1319. 10.1111/tpj.15390
 
5.
Álvarez-Berbel I., Espargaró A., Viayna A., Caballero A.B., Busquets M.A., Gámez P., Luque F.J., & Sabaté R., (2022). Three to Tango: inhibitory effect of quercetin and apigenin on acetylcholinesterase, amyloid-β aggregation and acetylcholinesterase–amyloid interaction. Pharmaceutics. 14(11), 2342.
 
6.
Athipornchai A., Ketpoo P., & Saeeng R., (2020). Acetylcholinesterase inhibitor from Tabernaemontana pandacaqui flowers. Natural Product Communications. 15.
 
7.
Azam S., Park J.-Y., Kim I.-S., & Choi D.-K., (2022). Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseases. Biomedicines. 10(1), 154. 10.3390/biomedicines10010154
 
8.
Banns H., Hebb C., & Mann S.P, (1977). The synthesis of acetylcholine from acetyl-CoA, acetyl-dephospho-CoA and acetylpantetheine phosphate by choline acetyltransfer. Journal of Neurochemistry. 29(3), 433–437.
 
9.
Basile M.S., Bramanti P., & Mazzon E., (2022). Inosine in neurodegenerative diseases: from the bench to the bedside. Molecules (Basel, Switzerland). 27(14), 4644. 10.3390/molecules27144644
 
10.
Baysal İ., Tatli I., Goger F., Kirimer N., Kahraman C., (2019). Acetylcholinesterase inhibitory activities and LC-MS analysis of the antioxidant Ferula caspica M. Bieb. and F. halophila Peşmen extracts. Journal of Research in Pharmacy. 23, 543–551. 10.12991/jrp.2019.161.
 
11.
Bhuvanendran S., Hanapi N.A., Ahemad N., Othman I., Yusof S.R., & Shaikh M.F., (2019). Embelin, a potent molecule for Alzheimer’s disease: a proof of concept from blood–brain barrier permeability, acetylcholinesterase inhibition and molecular dockings. Frontiers in Neuroscience. 13, 495. 10.3389/fnins.2019.00495
 
12.
Budryn G., Majak I., Grzelczyk J., Szwajgier D., Rodríguez-Martínez A., & Pérez-Sánchez H., (2022). Hydroxybenzoic acids as acetylcholinesterase inhibitors: calorimetric and docking simulation studies. Nutrients. 14(12), 2476. 10.3390/nu14122476
 
13.
Bugnon M., Röhrig U.F., Goullieux M., Perez M.A.S., Daina A., Michielin O., Zoete V., 2024. SwissDock (2024). Major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina. Nucleic Acids Research. 52(W1), W324–W332. 10.1093/nar/gkae300
 
14.
Chan E., & Lim T., (2007). Total phenolic content and antioxidant activity of leaves and rhizomes of some ginger species in Peninsular Malaysia. The Gardens’ Bulletin, Singapore. 59, 47–56.
 
15.
Čolović M., (2009). Folic acid effects on the acetyl cholinesterase activities in different tissues of a rat. Serbian Journal of Experimental and Clinical Research. 10 (3), 85–88.
 
16.
Duangupama T., Pratuangdejkul J., Chongruchiroj S., Pittayakhajonwut P., Intaraudom C., Tadtong S., Nunthanavanit P., Samee W., He Y.W., Tanasupawat S., & Thawai C., (2023). New insights into the neuroprotective and beta-secretase1 inhibitor profiles of tirandamycin B isolated from a newly found Streptomyces composti sp. nov. Scientific Reports. 13(1), 4825. 10.1038/s41598-023-32043-3
 
17.
Ellman G.L., Courtney K.D., Andres V., & Featherstone R.M., (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology. 7(2), 88–95. 10.1016/0006-2952(61)90145-9
 
18.
Falkenburger B., (2017). ExPPNing how acetylcholine improves gait in Parkinson’s disease: an editorial highlight for “Deletion of the Vesicular Acetylcholine Transporter from Pedunculopontine/laterodorsal tegmental neurons modifies gait.” Journal of Neurochemistry. 140(5), 688–691. 10.1111/jnc.13899
 
19.
Fernstrom J.D., (1981). Effects of precursors on brain neurotransmitter synthesis and brain functions. Diabetologia. (Vol. 20(Suppl 1), 281–289). 10.1007/BF00254494
 
20.
Filograna R., Civiero L., Ferrari V., Codolo G., Greggio E., Bubacco L., … Beltramini M., Bisaglia M. (2015). Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE(2)-M17 neuroblastoma cell lines upon differentiation. PLoS One. 10(8), 1–18. 10.1371/journal.pone.0136769
 
21.
Gangoda D.M., Saiyed M.S., Pathan S.R., Sharma K.B., Patel V.A., Sachdeva P.D., Patel M.Y., & Patel M.D., (2023). Enhanced neuroprotective synergy of atorvastatin and magnesium L-threonate in a rat model of Alzheimer›’s disease induced by aluminum chloride. Cureus. 15(11), e48400. 10.7759/cureus.48400
 
22.
Garcimartín A., López-Oliva M.E., González M.P., Sánchez-Muniz F.J., & Benedí J., (2017). Hydrogen peroxide modifies both activity and isoforms of acetylcholinesterase in human neuroblastoma SH-SY5Y cells. Redox Biology. 12(March), 719–726. 10.1016/j.redox.2017.04.004
 
23.
Gießel J.M., Serbian I., Loesche A., Csuk R., (2019). Substituted cinnamic anhydrides act as selective inhibitors of acetylcholinesterase. Bioorganic Chemistry. 90, 103058. 10.1016/j.bioorg.2019.103058
 
24.
Grodner B., Pisklak D., M., Szeleszczuk Ł., (2024). Succinimide derivatives as acetylcholinesterase inhibitors—in silico and in vitro studies. Current Issues in Molecular Biology. 46(6), 5117–5130. 10.3390/cimb46060307
 
25.
Hadavi D., & Poot A.A., (2016). Biomaterials for the treatment of Alzheimer’s disease. Frontiers in Bioengineering and Biotechnology. 4, 49. 10.3389/fbioe.2016.00049
 
26.
Hashim F.J., Mathkor T.H., Hussein H., & Shawkat M.S., (2017). GC-MS and FTIR Aanalysis of Moringa oleifera leaves different extracts and evaluation of their Antioxidant activity. Asian Journal of Microbiology, Biotechnology and Environmental Sciences. 19(4), 861–871.
 
27.
Hashim F.J., Vichitphan S., Boonsiri P., & Vichitphan K., (2021). Neuroprotective assessment of Moringa oleifera leaves extract against oxidative-stress-induced cytotoxicity in SHSY5Y neuroblastoma cells. Plants (Basel, Switzerland). 10(5), 889. 10.3390/plants10050889
 
28.
Hassan I., Wan Ibrahim W., Binti Mohamat Yusuf F., Ahmad S.A., & Ahmad S., (2021). Vitexin, isovitexin and other biochemical constituent of Ficus deltoidea leaf extract in 80% methanol inhibits cholinesterase enzymes on Javanese Medaka (Oryzias Jjavanicus) model. Journal of Research in Applied and Basic Medical Sciences. 7(4), 179–194. 10.1177/1934578X20911488
 
29.
Hwang E., Park S.-Y., Yin C.S., Kim H.-T., Kim Y.M., & Yi T.H., (2017). Antiaging effects of the mixture of Panax ginseng and Crataegus pinnatifida in human dermal fibroblasts and healthy human skin. Journal of Ginseng Research. 41(1), 69–77. 10.1016/j.jgr.2016.01.001
 
30.
Imramovsky A., Stepankova S., Vanco J., Pauk K., Monreal-Ferriz J., Vinsova J., Jampilek J., (2012). Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking. Molecules (Basel, Switzerland). 17(9), 10142–10158. 10.3390/molecules170910142
 
31.
Kakihana M., Yamazaki N., Nagaoka A., (1989). Effects of idebenone on the levels of acetylcholine, choline, free fatty acids, and energy metabolites in the brains of rats with cerebral ischemia. Archives of Gerontology and Geriatrics. 8(3), 247–256.
 
32.
Kandimalla R., & Reddy P.H., (2017). Therapeutics of Nneurotransmitters in Alzheimer’s disease. Journal of Alzheimer’s Disease. 57(4), 1049–1069. 10.3233/JAD-161118
 
33.
Kawamoto H., Takeshita F., & Murata K., (2019). Inhibitory effects of essential oil extracts from Panax ginseng against β-secretase and cholinesterases. Natural Product Communications. 14(8), 3–4. 10.1177/1934578X19873443
 
34.
Khairullah A.R., Solikhah T.I., Nur A., Ansori M., Fadholly A., Ramandinianto S.C., … Ansharieta R., Widodo A., Riwu K.H.P., Putri N., Proboningrat A., Kusala M.K.J., Rendragraha B.W., Putra A.R.S., Anshori A., (2020). A review of an important medicinal plant: Alpinia galanga (L.) Willd. Systematic Reviews in Pharmacy. 11(10), 387–395. 10.31838/srp.2020.10.62
 
35.
Levy A., Kong R.M., Stillman M.J., Shukitt-Hale B., Kadar T., Rauch T.M., Lieberman H.R, (1991). Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats. Pharmacology Biochemistry and Behavior. 39(3), 781–786.
 
36.
Li B., Huang A.L., Zhang Y.L., Li Z., Ding H.W., Huang C., Meng X.M., & Li J., (2017). Design, synthesis and evaluation of hesperetin derivatives as potential multifunctional anti-Alzheimer agents. Molecules (Basel, Switzerland). 22(7), 1067. 10.3390/molecules22071067
 
37.
Li H., Wang X., Li P., Li Y., & Wang H., (2008). Comparative study of antioxidant activity of grape (Vitis vinifera) seed powder assessed by different methods. Journal of Food and Drug Analysis. 16(6), 67–73.
 
38.
Lo C.Y., Liu P.L., Lin L.C., Chen Y.T., Hseu Y.C., Wen Z.H., & Wang H.M., (2013). Antimelanoma and antityrosinase from Alpinia galangal constituents. The Scientific World Journal. 2013, 186505. 10.1155/2013/186505
 
39.
Mugundhan V., Arthanari A., & Parthasarathy P.R., (2024). Protective effect of ferulic acid on acetylcholinesterase and amyloid beta peptide plaque formation in Alzheimer’s disease: An in vitro study. Cureus. 16(2), e54103. 10.7759/cureus.54103
 
40.
Murata K., Ishida Y., Nishio A., Nakagawa S., Kawamoto H., & Matsuda H., (2017). Screening of spice extracts possessing anti-acetylcholinesterase activity and active principle of bitter ginger, rhizome of Zingiber zerumbet. Natural Product Communications. 12(7), 1053–1056. 10.1177/1934578x1701200713
 
41.
Naddafi M., Mohammadi H., and Karami M., (2021). The effect of crocetin and rutin on acetylcholinesterase and butyrylcholinesterase enzymes reactivation in acute poisoning by diazinon in mice. Eurasian Chemical Communications. 3(5), 310–318. 10.22034/ecc.2021.277488.1150
 
42.
Nguyen V., Taine E.G., Meng D., Cui T., & Tan W., (2024). Chlorogenic acid: a systematic review on the biological functions, mechanistic actions, and therapeutic potentials. Nutrients. 16(7), 924. 10.3390/nu16070924
 
43.
Nouri Z., Fakhri S., El-Senduny F.F., Sanadgol N., Abd-ElGhani G.E., Farzaei M.H., Chen J.T., (2019). On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective. Biomolecules. 9(11), 690. 10.3390/biom9110690
 
44.
Nwidu L., Elmorsy E., Aprioku J., Siminialayi I., & Carter W., (2018). In vitro anti-cholinesterase and antioxidant activity of extracts of Moringa oleifera plants from Rivers State, Niger Delta, Nigeria. Medicines. 5(3), 71. 10.3390/medicines5030071
 
45.
Olennikov D.N., Kashchenko N.I., Chirikova N.K., Akobirshoeva A., Zilfikarov I.N., Vennos C., (2017). Isorhamnetin and quercetin derivatives as anti-acetylcholinesterase principles of marigold (Calendula officinalis) flowers and preparations. International Journal of Molecular Sciences. 18(8), 1685. 10.3390/ijms18081685
 
46.
Ong W.Y., Farooqui T., Koh H.L., Farooqui A.A., & Ling E.A., (2015). Protective effects of ginseng on neurological disorders. Frontiers in Aging Neuroscience. 7(JUN), 1–13. 10.3389/fnagi.2015.00129
 
47.
Ono K., & Tsuji M., (2019). Pharmacological potential of cilostazol for Alzheimer’s disease. Frontiers in Pharmacology. 10, 559. 10.3389/fphar.2019.00559
 
48.
Pagano G., Rengo G., Pasqualetti G., Femminella G.D., Monzani F., Ferrara N., & Tagliati M., (2015). Cholinesterase inhibitors for Parkinson’s disease: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry. 86(7), 767–773. 10.1136/jnnp-2014-308764
 
49.
Pastene-Burgos S., Muñoz-Nuñez E., Quiroz-Carreño S., Pastene-Navarrete E., Espinoza Catalan L., Bustamante L., Alarcón-Enos J., (2024). Ceanothanes derivatives as peripheric anionic site and catalytic active site inhibitors of acetylcholinesterase: insights for future drug design. International Journal of Molecular Sciences. 25(13), 7303. 10.3390/ijms25137303
 
50.
Pérez Gutiérrez R.M., Rodríguez-Serrano L.M., Laguna-Chimal J.F., de la Luz Corea M., Paredes Carrera S.P., & Téllez Gomez J., (2024). Geniposide and harpagoside functionalized cerium oxide nanoparticles as a potential neuroprotective. International Journal of Molecular Sciences. 25(8), 4262. 10.3390/ijms25084262
 
51.
Phupaboon S., Hashim F.J., Punyauppa-Path S., Kanpipit N., Klinsukon C., and Saowakoon S., 2025. Formulation, characterization and effectiveness of microencapsulated phytochemicals-derived essential oil against animal-pathogenic bacteria: in vitro and in silico studies. International Journal of Veterinary Science. 14(5), 998–1007. Accepted: 13-May-25. 10.47278/journal.ijvs/2025.xxx
 
52.
Punyauppa-Path S., Phupaboon S., Kiatprasert P., Toomthong P., Piyadeatsoontorn S., Thonsri U., Sawaengkaew J., Supawannaviwat N., Phumkhachorn P., .... Rattanachaikunsopon P., (2025). Protein digestibility, protein patterns, and antioxidant activities of quinoa natto supplemented with Thai traditional herbs. Natural Resources for Human Health. 5(2), 217–226. 10.53365/nrfhh/200471
 
53.
Remya C., Dileep K.V., Variyar E.J., Omkumar R.V., & Sadasivan C., (2023). Lobeline: Aa multifunctional alkaloid modulates cholinergic and glutamatergic activities. IUBMB Life. 75, 844–855.
 
54.
Romero-Márquez J., Navarro-Hortal M., Jiménez-Trigo V., Muñoz Ollero P., Forbes T., Esteban Muñoz A., Giampieri F., Noya I., Bullon P., Vera-Ramírez L., Battino M., González C., Quiles J, (2022). An olive-derived extract 20% rich in hydroxytyrosol prevents β-amyloid aggregation and oxidative stress, two features of Alzheimer’s disease, via SKN-1/NRF2 and HSP-16.2 in Caenorhabditis elegans. Antioxidants. 11, 629. 10.3390/antiox11040629.
 
55.
Rosa A., Pollastro F., Sogos V., & Piras F., (2025). Comparative evaluation of cytotoxic and apoptotic effects of natural compounds in SH-SY5Y neuroblastoma cells in relation to their physicochemical properties. Molecules. 30(8), 1742.
 
56.
Scozzafava A., Kalın P., Supuran C.T., Gülçin İ., & Alwasel S.H., (2015). The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII). Journal of Enzyme Inhibition and Medicinal Chemistry. 30(6), 941–946. 10.3109/14756366.2014.999236
 
57.
Sezen Karaoğlan E., Hancı H., Koca M., & Kazaz C., (2023). Some bioactivities of isolated apigenin-7-O-glucoside and luteolin-7-O-glucoside. Applied Sciences. 13(3), 1503. 10.3390/app13031503
 
58.
Shi W., Zhang G., Liao Y., Fei X., Gong D., Hu X., (2023). Anti-acetylcholinesterase mechanism of kaempferol and its synergistic effect with galanthamine hydrobromide, Food Bioscience. 56(6), 103174,. 10.1016/j.fbio.2023.103174
 
59.
Shin S., Lee J.-A., Son D., Park D., Jung E., Shin S., … Jung E., (2017). Anti-skin-aging activity of a standardized extract from Panax ginseng leaves in vitro and in human volunteer. Cosmetics. 4(2), 18. 10.3390/cosmetics4020018
 
60.
Sinagawa-García S., Martínez-Ávila G., López-Flores A., Sánchez-González E., Aguirre-Arzola V., Torres-Acosta R., … Ariel Torres-Castillo J., Olivares-Sáenz E., Osorio-Hernández E., Gutiérrez-Díez D., (n.d. 2013). Moringa oleifera: phytochemical detection, antioxidants, enzymes and antifugal properties. Phyton-International Journal of Experimental Botany. 82(0031 9457), 193–202.
 
61.
Sun W., Chen L., Zheng W., Wei X., Wu W., Duysen E.G., & Jiang W., (2017). Study of acetylcholinesterase activity and apoptosis in SH-SY5Y cells and mice exposed to ethanol. Toxicology. 384, 33–39. 10.1016/j.tox.2017.04.007.
 
62.
Vayupharp B., & Laksanalamai V., (2012). Recovery of antioxidants from grape seeds and its application in fried food. Journal of Food Processing & Technology. 03(04), 1–6. 10.4172/2157-7110.1000152
 
63.
Wang C., Cui X., Dong Z., Liu Y., Xia P., Wang X., Zhang Z., Yu S., Wu S., Liu H., Zong S., & Lu Z., (2024). Attenuated memory impairment and neuroinflammation in Alzheimer’s disease by aucubin via the inhibition of ERK-FOS axis. International Immunopharmacology. 126, 111312. 10.1016/j.intimp.2023.111312
 
64.
Wang Y., Cheng Q., Su Q., Yu X., & Shen T., & Yang X., & Jia W., (2022). Aesculin offers increased resistance against oxidative stress and protective effects against Aβ-induced neurotoxicity in Caenorhabditis elegans. European Journal of Pharmacology. 917, 174755. 10.1016/j.ejphar.2022.174755
 
65.
Wharton W., Stein J.H., Korcarz C., Sachs J., Olson S.R., Zetterberg H., Dowling M., Ye S., Gleason C.E., Underbakke G., Jacobson L.E., Johnson S.C., Sager M.A., Asthana S., & Carlsson C.M., (2012). The effects of ramipril in individuals at risk for Alzheimer’s disease: results of a pilot clinical trial. Journal of Alzheimer’s Disease: JAD. 32(1), 147–156. 10.3233/JAD-2012-120763
 
66.
Yuan Y., Shan X., Men W., Zhai H., Qiao X., Geng L., & Li C., (2020). The effect of crocin on memory, hippocampal acetylcholine level, and apoptosis in a rat model of cerebral ischemia. Biomedicine & Pharmacotherapy. 130, 110543. 10.1016/j.biopha.2020.110543
 
67.
Zhong Z., Han J., Zhang J., Xiao Q., Hu J., & Chen L., (2018). Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Design, Development and Therapy. 12, 1479–1489. 10.2147/DDDT.S160776
 
eISSN:2583-1194
Journals System - logo
Scroll to top